• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白溶解基因多态性(纤溶酶原激活物抑制剂 1 型 4G/5G、因子 XIII Val34Leu 和血管紧张素转换酶 I/D)与特发性不孕女性的相关性。

Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.

机构信息

Faculty of Medicine, Institute of Forensic Medicine, University of Belgrade.

Faculty of Applied Ecology Futura, Metropolitan University, Belgrade, Serbia.

出版信息

Blood Coagul Fibrinolysis. 2021 Mar 1;32(2):103-107. doi: 10.1097/MBC.0000000000000995.

DOI:10.1097/MBC.0000000000000995
PMID:33555692
Abstract

During normal pregnancy depressed fibrinolytic system is caused by changes in many factors, which could be influenced by different gene polymorphisms. The aim of this study was to investigate the combination of fibrinolysis-related gene polymorphisms in women with idiopathic infertility. We genotype polymorphisms 4G/5G in plasminogen activator inhibitor type 1 (PAI-1), Val34Leu in factor XIII (FXIII) and I/D in angiotensin-converting enzyme (ACE) gene. The patients group consisted of 83 females with idiopathic infertility, while the control group included 121 females with at least one born child. The alleles and genotypes distributions showed no significant differences between analyzed groups. Although higher frequency of PAI-1 5G5G genotype in patients did not reach statistical significance, 5G5G genotype of PAI-1 in combination with ValVal genotype of FXIII leads to higher risk for infertility (P < 0.05). In addition, when we added ACE I/D polymorphism in analysis, the 4G in PAI-1 and D allele in ACE, showed protective effect in combination with FXIII polymorphism (P < 0.05). The finding that combined homozygosity of 5G of PAI-1, commonly associated with greater fibrinolytic activity and bleeding tendency, in combination with Val genotype of FXIII impose a risk for female idiopathic infertility. The protective effect of alleles 4G (PAI-1) and D (ACE) suggest that different combinations of polymorphisms influencing fibrinolysis could lead to better established hemostatic balance and reproductive success. Further analyses, with larger number of samples, as well as assessment of additional biochemical parameters of fibrinolysis, should be performed to clarify the role of gene polymorphisms on fibrinolysis and consequently their influence on reproductive success.

摘要

在正常妊娠期间,许多因素会导致纤溶系统受到抑制,这些因素可能受到不同基因多态性的影响。本研究旨在探讨纤维蛋白溶解相关基因多态性在特发性不孕妇女中的组合。我们对纤溶酶原激活物抑制剂 1(PAI-1)的 4G/5G 多态性、凝血因子 XIII 的 Val34Leu(FXIII)多态性和血管紧张素转换酶(ACE)基因的 I/D 多态性进行了基因分型。患者组包括 83 名特发性不孕女性,对照组包括 121 名至少生育过一名子女的女性。分析组之间的等位基因和基因型分布无显著差异。虽然患者 PAI-1 5G5G 基因型的频率较高,但未达到统计学意义,PAI-1 的 5G5G 基因型与 FXIII 的 ValVal 基因型相结合会增加不孕的风险(P<0.05)。此外,当我们在分析中加入 ACE I/D 多态性时,PAI-1 的 4G 和 ACE 的 D 等位基因与 FXIII 多态性相结合,表现出保护作用(P<0.05)。PAI-1 的 5G 常见于纤维蛋白溶解活性增加和出血倾向增加,与 FXIII 的 Val 基因型相结合会增加女性特发性不孕的风险。等位基因 4G(PAI-1)和 D(ACE)的保护作用表明,影响纤溶的多态性的不同组合可能导致更好的止血平衡和生殖成功。应进行进一步的分析,使用更大的样本量,并评估纤溶的其他生化参数,以阐明基因多态性对纤溶的作用及其对生殖成功的影响。

相似文献

1
Combinations of fibrinolytic gene polymorphisms (plasminogen activator inhibitor type 1 4G/5G, factor XIII Val34Leu and angiotensin-converting enzyme I/D) in women with idiopathic infertility.纤维蛋白溶解基因多态性(纤溶酶原激活物抑制剂 1 型 4G/5G、因子 XIII Val34Leu 和血管紧张素转换酶 I/D)与特发性不孕女性的相关性。
Blood Coagul Fibrinolysis. 2021 Mar 1;32(2):103-107. doi: 10.1097/MBC.0000000000000995.
2
[Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].原发性高血压合并血脂异常患者纤溶酶原激活物抑制剂-1(PAI-1)4G/5G与血管紧张素转换酶(ACE)I/D基因多态性及纤溶活性研究
Pol Arch Med Wewn. 2005 Jan;113(1):7-20.
3
Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss.纤溶酶原激活物抑制剂1 4G/5G多态性与凝血因子XIII Val34Leu多态性:纤维蛋白溶解功能受损与早期流产
Clin Chem. 2003 Jul;49(7):1081-6. doi: 10.1373/49.7.1081.
4
Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.血管紧张素转化酶 D/I 和纤溶酶原激活物抑制剂-1 4G/5G 基因多态性与多囊卵巢综合征患者自然流产风险增加相关。
J Endocrinol Invest. 2010 Feb;33(2):77-82. doi: 10.1007/BF03346557. Epub 2009 Jul 28.
5
[The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].[血管紧张素I转换酶(ACE)基因的I/D多态性及纤溶酶原激活物抑制剂(PAI-1)基因启动子的4G/5G多态性对原发性高血压合并血脂异常患者止血系统的影响]
Ann Acad Med Stetin. 2005;51(1):95-105.
6
Prevalence of coagulation factor XIII and plasminogen activator inhibitor-1 gene polymorphisms among Egyptian women suffering from unexplained primary recurrent miscarriage.埃及不明原因原发性复发性流产女性中凝血因子 XIII 和纤溶酶原激活物抑制剂-1 基因多态性的流行情况。
J Reprod Immunol. 2014 Jun;103:18-22. doi: 10.1016/j.jri.2014.02.007. Epub 2014 Mar 19.
7
Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion.复发性自然流产患者纤溶酶原激活物抑制剂-1、血管紧张素转换酶及凝血因子 XIII 基因的多态性
J Matern Fetal Neonatal Med. 2011 Mar;24(3):545-8. doi: 10.3109/14767058.2010.511331. Epub 2010 Sep 7.
8
Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients.中国患者中纤溶酶原激活物抑制剂-1 4G/4G基因型与2型糖尿病肾病的关联
Kidney Int. 2000 Feb;57(2):632-8. doi: 10.1046/j.1523-1755.2000.00884.x.
9
Coexistence of ACE (I/D) and PAI-1 (4G/5G) gene variants in recurrent miscarriage in Polish population.波兰人群复发性流产中ACE(I/D)和PAI-1(4G/5G)基因变异的共存情况。
Ginekol Pol. 2016;87(4):271-6. doi: 10.17772/gp/62203.
10
Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.代谢病房受试者血浆纤溶酶原激活物抑制剂-1(PAI-1)抗原水平:与PAI-1及血管紧张素转换酶(ACE)基因多态性的关系
Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2082-7. doi: 10.1161/01.atv.17.10.2082.

引用本文的文献

1
Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Presenting as Recurrent Ischemic Stroke: The Microthrombi Shower.纤溶酶原激活物抑制剂-1 4G/5G多态性表现为复发性缺血性卒中:微血栓阵雨
Cureus. 2022 Apr 4;14(4):e23828. doi: 10.7759/cureus.23828. eCollection 2022 Apr.